Le Lézard
Classified in: Environment, Science and technology
Subject: BFA

Advanced Charging Technologies Unveils Transformative Rebrand, Reinforcing Commitment to Innovation

FOUNTAIN VALLEY, Calif., Sept. 25, 2023 /CNW/ -- Advanced Charging Technologies, Inc. (ACT) proudly reveals a transformative rebrand, epitomizing dedication to innovation, excellence, and profound relationships. This rebrand transcends visuals, symbolizing ACT's realignment with cutting-edge solutions and strong core values: trust, unity, ownership, family, growth, and investment.

"ACT is committed to a sustainable future, challenging the green tech status quo," says Michael K. Nelson, President at ACT. "The rebrand of our logo and the launch of our new website are the first of many steps into the future."

The new visual identity mirrors ACT's technological innovation. As technology reshapes the world, ACT's rebrand becomes pivotal to mirror its advanced solutions, which reshape energy landscapes. This revitalized identity encapsulates the sophistication and innovation synonymous with ACT's comprehensive suite of charging and energy management solutions, catering to a wide range of industries and needs.

As part of its evolution, ACT unveils a new state-of-the-art website. This online platform reflects the dedication to innovation, providing an intuitive space to explore advanced solutions and sustainable energy initiatives.

Central to ACT's rebrand is a foundation of trust, reliability, and unity. ACT is a family, in addition to a manufacturer, and regards its clients as integral to that family. Trust and exceptional performance are the foundation for ACT's pursuit to elevate efficiencies and direct initiatives toward sustainable energy solutions.

More than merely being a charging equipment provider, ACT empowers informed decision-making through its diverse range of products and services, including advanced analytics, fleet optimization, and green energy integration. Holding ISO 9001-2015 certification, ACT underscores its commitment to maintaining the highest standards of quality and reliability in all aspects of its operations. This dedication makes ACT a wellspring of guidance on clients' paths toward a more sustainable and efficient future.

As ACT expands globally, its essence remains unchanged. A promise of consistency persists, regardless of location. This rebrand isn't about altering identity; it's about spotlighting unwavering dedication on a worldwide stage.

'Empowering Global Progress through Technological Excellence' transcends vision; it's ACT's blueprint. Leading as a tech manufacturer and driver of global innovation, ACT is resolute in shaping the future through quality, creativity, and growth.

About Advanced Charging Technologies (ACT):

Established in 2009, Advanced Charging Technologies, Inc. (ACT) is a recognized leader in integrated solutions for forklift battery and charging technologies. Committed to constant innovation, ACT drives industry transformation with cutting-edge products. Their portfolio includes smart industrial appliances that set new standards and connected fleet solutions that enhance business efficiency. ACT has deployed over 60,000 chargers worldwide, reflecting their dedication to progress through technological excellence. Rooted in unwavering service and ethics, ACT is devoted to delivering exceptional quality products and services across the globe.

Website: https://act-chargers.com/
Social Media: https://www.linkedin.com/company/advanced-charging-technologies/ 

SOURCE Advanced Charging Technologies

These press releases may also interest you

at 12:35
Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe diseases, today announced positive preclinical data for its lead small molecule QPCTL inhibitor, SC-2882. The data was also presented today by...

at 12:30
Blueprint Medicines Corporation today announced data showcasing its commitment to advance the scientific understanding and treatment of systemic mastocytosis (SM) at the 65th American Society of Hematology (ASH)...

at 12:05
Rallybio Corporation , a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today presented details from the Rallybio Fetal and...

at 12:05
Genmab A/S and AbbVie today announced new data from the ongoing phase 1/2 EPCOREtm NHL-1 clinical trial investigating epcoritamab (DuoBody® CD3xCD20), a T-cell engaging bispecific antibody administered subcutaneously, demonstrated an overall...

at 11:35
bluebird bio, Inc. ("bluebird bio" or "bluebird") today announced new and updated efficacy, safety and health-related quality of life (HRQoL) data from the Phase 1/2 HGB-206 Group C and Phase 3 HGB-210 studies of lovotibeglogene autotemcel...

at 11:35
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the primary analysis of the Phase III HAVEN 7 study reinforced the efficacy and safety of Hemlibra® (emicizumab-kxwh) in previously untreated or minimally...

News published on and distributed by: